Allelotypic Characteristics of Thorotrast-Induced Intrahepatic Cholangiocarcinoma: Comparison to Liver Cancers not Associated with Thorotrast

Radiation Research

Volumn 161, Issue 2, 2004, Pages 235-243

  Liu, Duo ^a   Wada, Ikuo ^a   Tateno, Hiroo ^b   Ogino, Daisuke ^a   Suzuki, Michiko ^a   Li, Li ^a   Lu, Wang ^a   Kojiro, Masamichi ^c   Fukayama, Masahisa ^d   Okabe, Hiroshi ^e   Fukumoto, Manabu ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b Miyagi Cancer Center   (Japan)

^c KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

THORIUM DIOXIDE;

ADULT; AGED; ARTICLE; BILE DUCT; BILE DUCT CARCINOMA; CARCINOGENESIS; CHROMOSOME 19; CHROMOSOME 9; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; GENE LOCUS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LIVER CARCINOMA; LIVER CELL; LIVER CELL CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; STEM CELL;

AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; DNA, NEOPLASM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LIVER NEOPLASMS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; THORIUM DIOXIDE;

EID: 9144274925     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR3118     Document Type: Article

References (35)

1. Liver Cancer Study Group of Japan, Primary liver cancer in Japan: Clinicopathologic features and results of surgical treatment. Ann. Surg. 211, 277-287 (1990).
2. K. Shiota, J. Taguchi, O. Nakashima, M. Nakashima and M. Kojiro, Clinicopathologic study on cholangiolocellular carcinoma. Oncol. Rep. 8, 263-268 (2001).
3. M. A. Feitelson, B. Sun, N. L. Satiroglu Tufan, J. Liu, J. Pan and Z. Lian, Genetic mechanisms of hepatocarcinogenesis. Oncogene 21, 2593-2604 (2002).
4. P. J. Thuluvath, R. Rai, A. C. Venbrux and C. J. Yeo, Cholangiocarcinoma: A review. Gastroenterologist 5, 306-315 (1997).
5. J. D. Abbatt, History of the use and toxicity of thorotrast. Environ. Res. 18, 6-12 (1979).
6. T. Mori, C. Kido, K. Fukutomi, Y. Kato, S. Hatakeyama, R. Machinami, Y. Ishikawa, T. Kumatori, F. Sasaki and T. Sobue, Summary of entire Japanese thorotrast follow-up study: Updated 1998. Radiat. Res. 152 (Suppl.), S84-S87 (1999).
7. E. R. Fearon and B. Vogelstein, Genetic model for colorectal tumorigenesis. Cell 61, 759-767 (1990).
8. N. Wong, P. Lai, E. Pang, L. F. Fung, Z. Sheng, V. Wong, W. Wang, Y. Hayashi, E. Perlman and P. J. Johnson, Genomic aberrations in human hepatocellular carcinomas of differing etiologies. Clin. Cancer Res. 6, 4000-4009 (2000).
9. S. H. Koo, C. H. Ihm, K. C. Kwon, J. W. Park, J. M. Kim and G. Kong, Genetic alterations in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Cancer Genet. Cytogenet. 130, 22-28 (2001).
10. C. Dib, S. Faure, C. Fizames, D. Samson, N. Drouot, A. Vignal, P. Millasseau, S. Marc, J. Hazan and J. A. Weissenbach, A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 380, 152-154 (1996).
11. H. Momoi, H. Okabe, T. Kamikawa, S. Satoh, I. Ikai, M. Yamamoto, A. Nakagawara, Y. Shimahara, Y. Yamaoka and M. Fukumoto, Comprehensive allelotyping of human intrahepatic cholangiocarcinoma. Clin. Cancer Res. 7, 2648-2655 (2001).
12. H. Okabe, I. Ikai, K. Matsuo, S. Satoh, H. Momoi, T. Kamikawa, N. Katsura, R. Nishitai, O. Takeyama and Y. Yamaoka, Comprehensive allelotype study of hepatocellular carcinoma: Potential differences in pathways to hepatocellular carcinoma between hepatitis B virus-positive and -negative tumors. Hepatology 31, 1073-1079 (2000).
13. A. Goto, Y. Takebayashi, D. Liu, L. Li, T. Saiga, T. Mori, A. Yamadera and M. Fukumoto, Microdistribution of alpha particles in pathological sections of tissues from thorotrast patients detected by imaging plate autoradiography. Radiat. Res. 158, 54-60 (2002).
14. R. Kyomoto, H. Kumazawa, Y. Toda, N. Sakaida, A. Okamura, M. Iwanaga, M. Shintaku, T. Yamashita, H. Hiai and M. Fukumoto, Cyclin-D1-gene amplification is a more potent prognostic factor than its protein over-expression in human head-and-neck squamous-cell carcinoma. Int. J. Cancer 74, 576-581 (1997).
15. Y. Kanda, Y. Nishiyama, Y. Shimada, M. Imamura, H. Nomura, H. Hiai and M. Fukumoto, Analysis of gene amplification and overexpression in human esophageal-carcinoma cell lines. Int. J. Cancer 58, 291-297 (1994).
16. H. E. Giercksky, L. Thorstensen, H. Qvist, J. M. Nesland and R. A. Lothe, Comparison of genetic changes in frozen biopsies and microdissected archival material from the same colorectal liver metastases. Diagn. Mol. Pathol. 6, 318-325 (1997).
17. Y. Matsuda, Y. Amuro, K. Higashino, T. Hada, T. Yamamoto, M. Fujikura, K. Yamaguchi, S. Shimomura, H. Iijima and K. Kudo, Relation between markers for viral hepatitis and clinical features of Japanese patients with hepatocellular carcinoma: Possible role of alcohol in promoting carcinogenesis. Hepatogastroenterology 42, 151-154 (1995).
18. Y. Shiratori, S. Shiina, P. Y. Zhang, E. Ohno, T. Okudaira, D. A. Payawal, S. K. Ono-Nita, S. K. M. Imamura, N. Kato and M. Omata, Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan? Cancer 80, 2060-2067 (1997).
19. H. Oguchi, M. Miyasaka, S. Tokunaga, K. Hora, S. Ichikawa, T. Ochi, K. Yamada, M. Nagasawa, Y. Kanno and S. Furuta, Hepatitis virus infection (HBV and HCV) in eleven Japanese hemodialysis units. Clin. Nephrol. 38, 36-43 (1992).
20. O. Bluteau, J. C. Beaudoin, P. Pasturaud, J. Belghiti, D. Franco, P. Bioulac-Sage, P. Laurent-Puig and J. Zucman-Rossi, Specific association between alcohol intake, high grade of differentiation and 4q34-q35 deletions in hepatocellular carcinomas identified by high resolution allelotyping. Oncogene 21, 1225-1232 (2002).
21. A. Rashid, J. S. Wang, G. S. Qian, B. X. Lu, S. R. Hamilton and J. D. Groopman, Genetic alterations in hepatocellular carcinomas: Association between loss of chromosome 4q and p53 gene mutations. Br. J. Cancer 80, 59-66 (1999).
22. K. Bando, H. Nagai, S. Matsumoto, M. Koyama, N. Kawamura, M. Onda and M. Emi, Identification of a 1-cM region of common deletion on 4q35 associated with progression of hepatocellular carcinoma. Genes Chromosomes Cancer 25, 284-289 (1999).
23. A. Latil, O. Cussenot, G. Fournier, K. Driouch and R. Lidereau, Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: Identification of three independent regions. Cancer Res. 57, 1058-1062 (1997).
24. T. Chen, A. Sahin and C. M. Aldaz, Deletion map of chromosome 16q in ductal carcinoma in situ of the breast: Refining a putative tumor suppressor gene region. Cancer Res. 56, 5605-5609 (1996).
25. K. Driouch, F. Dorion-Bonnet, M. Briffod, M. H. Champeme, M. Longy and R. Lidereau, Loss of heterozygosity on chromosome arm 16q in breast cancer metastases. Genes Chromosomes Cancer 19, 185-191 (1997).
26. H. Iwabuchi, M. Sakamoto, H. Sakunaga, Y. Y. Ma, M. L. Carcangiu, D. Pinkel, T. L. Yang-Feng and J. W. Gray, Genetic analysis of benign, low-grade, and high-grade ovarian tumors. Cancer Res. 55, 6172-6180 (1995).
27. J. E. Mason, P. J. Goodfellow, P. E. Grundy and M. A. Skinner, 16q loss of heterozygosity and microsatellite instability in Wilms' tumor. J. Pediatr. Surg. 35, 891-896 (2000).
28. B. R. Balsara, J. Pei, A. De Rienzo, D. Simon, A. Tosolini, Y. Y. Lu, F. M. Shen, X. Fan, W. Y. Lin and J. R. Testa, Human hepatocellular carcinoma is characterized by a highly consistent pattern of genomic imbalances, including frequent loss of 16q23.1-24.1. Genes Chromosomes Cancer 30, 245-253 (2001).
29. M. C. Yakicier, P. Legoix, C. Vaury, L. Gressin, E. Tubacher, F. Capron, J. Bayer, C. Degott, C. Balabaud and J. Zucman-Rossi, Identification of homozygous deletions at chromosome 16q23 in aflatoxin B1 exposed hepatocellular carcinoma. Oncogene 20, 5232-5238 (2001).
30. 2/ M phase transition of the mammalian cell cycle. Proc. Natl. Acad. Sci. USA 95, 3419-3424 (1998).
31. J. R. Dunn, J. Garde, K. Dolan, J. R. Gosney, B. C. Oates, A. J. Watson, P. Fielding and J. K. Field, The evolution of loss of heterozygosity on chromosome 17 during the progression to Barrett's adenocarcinoma involves a unique combination of target sites in individual specimens. Clin. Cancer Res. 6, 4033-4042 (2000).
32. T. Nishimura, N. Nishida, T. Itoh, M. Kuno, M. Minata, T. Komeda, Y. Fukuda, I. Ikai, Y. Yamaoka and K. Nakao, Comprehensive allelotyping of well-differentiated human hepatocellular carcinoma with semiquantitative determination of chromosomal gain or loss. Genes Chromosomes Cancer 35, 329-339 (2002).
33. E. S. Gilbert, N. A. Koshurnikova, M. Sokolnikov, V. F. Khokhryakov, S. Miller, D. L. Preston, S. A. Romanov, N. S. Shilnikova, K. G. Suslova and V. V. Vostrotin, Liver cancers in Mayak workers. Radiat. Res. 154, 246-252 (2000).
34. H. Zhou, G. Randers-Pehrson, C. A. Waldren, D. Vannais, E. J. Hall and T. K. Hei, Induction of a bystander mutagenic effect of alpha particles in mammalian cells. Proc. Natl. Acad. Sci. USA 97, 2099-2104 (2000).
35. M. Imai, Y. Yanase, T. Nojiri, Y. Miyakawa and M. Mayumi, A receptor for polymerized human and chimpanzee albumins on hepatitis B virus particles co-occurring with HBeAg. Gastroenterology 76, 242-247 (1979).